Pharmaceutical Economics and Policy

4 valoración promedio
( 9 valoraciones por Goodreads )
 
9780195300956: Pharmaceutical Economics and Policy
Ver todas las copias de esta edición ISBN.
 
 

Book by Schweitzer Stuart O

"Sinopsis" puede pertenecer a otra edición de este libro.

Reseña del editor:

The pharmaceutical industry is praised as a world leader in high technology innovation and the creator of products that increase both longevity and quality of life for people throughout the world. At the same time, the industry is also criticized for its marketing and pricing practices and for its apparent anticompetitive responses to generic competition. Even its research and development priorities are criticized as being too closely driven by the goal of maximizing shareholder value, rather than the health of the public. Unfortunately, many of the critics of the industry fail to understand the complexities of the industry and its role in the nations healthcare system. This book uses the tools of economic analysis to explore the conflicting priorities and aims of the pharmaceutical industry, from both an American and worldwide perspective.

This is the second edition of a uniquely comprehensive and balanced discussion of pharmaceutical policy issues. All the chapters of the former edition have been fully re-written and extensively updated.

In addition, the book includes six new chapters on emerging topics such as the broadened role of FDA regulations and the increasing diversity of the industry. An entire chapter is devoted to the biotechnology industry and one to alternative medicines, often called "nutraceuticals." Another new chapter discusses segments of the industry that specialize in particular activities including generic drugs and drug delivery systems. The recent controversial expansion of Medicare to cover outpatient drugs is discussed in depth. The introduction is also updated to address the volatile pace of pharmaceutical innovation and how the pharmaceutical industry has responded to the emergence of managed care.

Biografía del autor:

Stuart O. Schweitzer is Professor of Health Economics in the Department of Health Services at the University of California, Los Angeles.

"Sobre este título" puede pertenecer a otra edición de este libro.

Comprar nuevo Ver libro

Gastos de envío: EUR 4,42
De Reino Unido a Estados Unidos de America

Destinos, gastos y plazos de envío

Añadir al carrito

Los mejores resultados en AbeBooks

1.

Schweitzer, Stuart O.
Publicado por Oxford University Press (2016)
ISBN 10: 0195300955 ISBN 13: 9780195300956
Nuevo Paperback Cantidad disponible: 1
Impresión bajo demanda
Librería
Ria Christie Collections
(Uxbridge, Reino Unido)
Valoración
[?]

Descripción Oxford University Press, 2016. Paperback. Condición: New. PRINT ON DEMAND Book; New; Publication Year 2016; Not Signed; Fast Shipping from the UK. No. book. Nº de ref. del artículo: ria9780195300956_lsuk

Más información sobre este vendedor | Contactar al vendedor

Comprar nuevo
EUR 53,28
Convertir moneda

Añadir al carrito

Gastos de envío: EUR 4,42
De Reino Unido a Estados Unidos de America
Destinos, gastos y plazos de envío

2.

Schweitzer, Stuart O.
Publicado por OUP USA (2006)
ISBN 10: 0195300955 ISBN 13: 9780195300956
Nuevo Cantidad disponible: > 20
Impresión bajo demanda
Librería
Books2Anywhere
(Fairford, GLOS, Reino Unido)
Valoración
[?]

Descripción OUP USA, 2006. HRD. Condición: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Nº de ref. del artículo: IQ-9780195300956

Más información sobre este vendedor | Contactar al vendedor

Comprar nuevo
EUR 50,85
Convertir moneda

Añadir al carrito

Gastos de envío: EUR 10,31
De Reino Unido a Estados Unidos de America
Destinos, gastos y plazos de envío

3.

Stuart O. Schweitzer
Publicado por OUP USA 2006-10-01, New York |Oxford (2006)
ISBN 10: 0195300955 ISBN 13: 9780195300956
Nuevo Tapa dura Cantidad disponible: 10
Librería
Blackwell's
(Oxford, OX, Reino Unido)
Valoración
[?]

Descripción OUP USA 2006-10-01, New York |Oxford, 2006. hardback. Condición: New. Nº de ref. del artículo: 9780195300956

Más información sobre este vendedor | Contactar al vendedor

Comprar nuevo
EUR 54,67
Convertir moneda

Añadir al carrito

Gastos de envío: EUR 6,87
De Reino Unido a Estados Unidos de America
Destinos, gastos y plazos de envío

4.

Schweitzer, Stuart O.
Publicado por Oxford University Press (2018)
ISBN 10: 0195300955 ISBN 13: 9780195300956
Nuevo Tapa dura Cantidad disponible: 19
Impresión bajo demanda
Librería
Murray Media
(North Miami Beach, FL, Estados Unidos de America)
Valoración
[?]

Descripción Oxford University Press, 2018. Hardcover. Condición: New. Never used! This item is printed on demand. Nº de ref. del artículo: 0195300955

Más información sobre este vendedor | Contactar al vendedor

Comprar nuevo
EUR 64,26
Convertir moneda

Añadir al carrito

Gastos de envío: EUR 1,63
A Estados Unidos de America
Destinos, gastos y plazos de envío

5.

Stuart O. Schweitzer
Publicado por Oxford University Press, United Kingdom (2006)
ISBN 10: 0195300955 ISBN 13: 9780195300956
Nuevo Tapa dura Cantidad disponible: 10
Impresión bajo demanda
Librería
The Book Depository
(London, Reino Unido)
Valoración
[?]

Descripción Oxford University Press, United Kingdom, 2006. Hardback. Condición: New. 2nd Revised edition. Language: English . Brand New Book ***** Print on Demand *****.The pharmaceutical industry is praised as a world leader in high technology innovation and the creator of products that increase both longevity and quality of life for people throughout the world. At the same time, the industry is also criticized for its marketing and pricing practices and for its apparent anticompetitive responses to generic competition. Even its research and development priorities are criticized as being too closely driven by the goal of maximizing shareholder value, rather than the health of the public. Unfortunately, many of the critics of the industry fail to understand the complexities of the industry and its role in the nations healthcare system. This book uses the tools of economic analysis to explore the conflicting priorities and aims of the pharmaceutical industry, from both an American and worldwide perspective. This is the second edition of a uniquely comprehensive and balanced discussion of pharmaceutical policy issues. All the chapters of the former edition have been fully re-written and extensively updated. In addition, the book includes six new chapters on emerging topics such as the broadened role of FDA regulations and the increasing diversity of the industry. An entire chapter is devoted to the biotechnology industry and one to alternative medicines, often called nutraceuticals. Another new chapter discusses segments of the industry that specialize in particular activities including generic drugs and drug delivery systems. The recent controversial expansion of Medicare to cover outpatient drugs is discussed in depth. The introduction is also updated to address the volatile pace of pharmaceutical innovation and how the pharmaceutical industry has responded to the emergence of managed care. Nº de ref. del artículo: APC9780195300956

Más información sobre este vendedor | Contactar al vendedor

Comprar nuevo
EUR 67,08
Convertir moneda

Añadir al carrito

Gastos de envío: GRATIS
De Reino Unido a Estados Unidos de America
Destinos, gastos y plazos de envío

6.

Stuart O. Schweitzer
Publicado por Oxford University Press, United Kingdom (2006)
ISBN 10: 0195300955 ISBN 13: 9780195300956
Nuevo Tapa dura Cantidad disponible: 10
Impresión bajo demanda
Librería
Book Depository International
(London, Reino Unido)
Valoración
[?]

Descripción Oxford University Press, United Kingdom, 2006. Hardback. Condición: New. 2nd Revised edition. Language: English . Brand New Book ***** Print on Demand *****. The pharmaceutical industry is praised as a world leader in high technology innovation and the creator of products that increase both longevity and quality of life for people throughout the world. At the same time, the industry is also criticized for its marketing and pricing practices and for its apparent anticompetitive responses to generic competition. Even its research and development priorities are criticized as being too closely driven by the goal of maximizing shareholder value, rather than the health of the public. Unfortunately, many of the critics of the industry fail to understand the complexities of the industry and its role in the nations healthcare system. This book uses the tools of economic analysis to explore the conflicting priorities and aims of the pharmaceutical industry, from both an American and worldwide perspective. This is the second edition of a uniquely comprehensive and balanced discussion of pharmaceutical policy issues. All the chapters of the former edition have been fully re-written and extensively updated. In addition, the book includes six new chapters on emerging topics such as the broadened role of FDA regulations and the increasing diversity of the industry. An entire chapter is devoted to the biotechnology industry and one to alternative medicines, often called nutraceuticals. Another new chapter discusses segments of the industry that specialize in particular activities including generic drugs and drug delivery systems. The recent controversial expansion of Medicare to cover outpatient drugs is discussed in depth. The introduction is also updated to address the volatile pace of pharmaceutical innovation and how the pharmaceutical industry has responded to the emergence of managed care. Nº de ref. del artículo: APC9780195300956

Más información sobre este vendedor | Contactar al vendedor

Comprar nuevo
EUR 67,38
Convertir moneda

Añadir al carrito

Gastos de envío: GRATIS
De Reino Unido a Estados Unidos de America
Destinos, gastos y plazos de envío

7.

Stuart O. Schweitzer
Publicado por Oxford University Press, USA (2006)
ISBN 10: 0195300955 ISBN 13: 9780195300956
Nuevo Tapa dura Cantidad disponible: 1
Librería
Ergodebooks
(RICHMOND, TX, Estados Unidos de America)
Valoración
[?]

Descripción Oxford University Press, USA, 2006. Hardcover. Condición: New. 2. Nº de ref. del artículo: DADAX0195300955

Más información sobre este vendedor | Contactar al vendedor

Comprar nuevo
EUR 68,22
Convertir moneda

Añadir al carrito

Gastos de envío: EUR 4,10
A Estados Unidos de America
Destinos, gastos y plazos de envío

8.

Stuart O. Schweitzer
Publicado por Oxford University Press
ISBN 10: 0195300955 ISBN 13: 9780195300956
Nuevo Tapa dura Cantidad disponible: > 20
Librería
BuySomeBooks
(Las Vegas, NV, Estados Unidos de America)
Valoración
[?]

Descripción Oxford University Press. Hardcover. Condición: New. 352 pages. Dimensions: 9.3in. x 5.9in. x 1.0in.The pharmaceutical industry is praised as a world leader in high technology innovation and the creator of products that increase both longevity and quality of life for people throughout the world. At the same time, the industry is also criticized for its marketing and pricing practices and for its apparent anticompetitive responses to generic competition. Even its research and development priorities are criticized as being too closely driven by the goal of maximizing shareholder value, rather than the health of the public. Unfortunately, many of the critics of the industry fail to understand the complexities of the industry and its role in the nations healthcare system. This book uses the tools of economic analysis to explore the conflicting priorities and aims of the pharmaceutical industry, from both an American and worldwide perspective. This is the second edition of a uniquely comprehensive and balanced discussion of pharmaceutical policy issues. All the chapters of the former edition have been fully re-written and extensively updated. In addition, the book includes six new chapters on emerging topics such as the broadened role of FDA regulations and the increasing diversity of the industry. An entire chapter is devoted to the biotechnology industry and one to alternative medicines, often called nutraceuticals. Another new chapter discusses segments of the industry that specialize in particular activities including generic drugs and drug delivery systems. The recent controversial expansion of Medicare to cover outpatient drugs is discussed in depth. The introduction is also updated to address the volatile pace of pharmaceutical innovation and how the pharmaceutical industry has responded to the emergence of managed care. This item ships from multiple locations. Your book may arrive from Roseburg,OR, La Vergne,TN. Hardcover. Nº de ref. del artículo: 9780195300956

Más información sobre este vendedor | Contactar al vendedor

Comprar nuevo
EUR 76,51
Convertir moneda

Añadir al carrito

Gastos de envío: GRATIS
A Estados Unidos de America
Destinos, gastos y plazos de envío

9.

Schweitzer, Stuart O.
Publicado por Oxford University Press
ISBN 10: 0195300955 ISBN 13: 9780195300956
Nuevo Tapa dura Cantidad disponible: > 20
Librería
Russell Books
(Victoria, BC, Canada)
Valoración
[?]

Descripción Oxford University Press. Hardcover. Condición: New. 0195300955 Special order direct from the distributor. Nº de ref. del artículo: ING9780195300956

Más información sobre este vendedor | Contactar al vendedor

Comprar nuevo
EUR 76,16
Convertir moneda

Añadir al carrito

Gastos de envío: EUR 5,75
De Canada a Estados Unidos de America
Destinos, gastos y plazos de envío

10.

Stuart O. Schweitzer
Publicado por Oxford University Press (2006)
ISBN 10: 0195300955 ISBN 13: 9780195300956
Nuevo Tapa dura Cantidad disponible: 1
Librería
Irish Booksellers
(Portland, ME, Estados Unidos de America)
Valoración
[?]

Descripción Oxford University Press, 2006. Condición: New. book. Nº de ref. del artículo: M0195300955

Más información sobre este vendedor | Contactar al vendedor

Comprar nuevo
EUR 85,31
Convertir moneda

Añadir al carrito

Gastos de envío: GRATIS
A Estados Unidos de America
Destinos, gastos y plazos de envío